The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention

Journal of Neuroscience

Volumn 33, Issue 6, 2013, Pages 2326-2337

  Parikh, Vinay ^a   St Peters, Megan ^b   Blakely, Randy D ^c   Sarter, Martin ^b  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; BEHAVIOR; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; GENE DELETION; IMMUNOBLOTTING; MALE; MICRODIALYSIS; MOUSE; NERVE STIMULATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYNAPTOSOME; TASK PERFORMANCE;

ACETYLCHOLINE; ANIMALS; ATTENTION; FEMALE; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRESYNAPTIC TERMINALS; RANDOM ALLOCATION;

EID: 84873311601     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4993-12.2013     Document Type: Article

References (57)

1. Apparsundaram S, Martinez V, Parikh V, Kozak R, Sarter M (2005) Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional taskperforming rats. J Neurosci 25:3851-3856. CrossRef Medline
2. Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68: 209-245. CrossRef Medline
3. Bales KR, Tzavara ET, Wu S, Wade MR, Bymaster FP, Paul SM, Nomikos GG (2006) Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-Aβ antibody. J Clin Invest 116:825-832. CrossRef Medline
4. Barwick KE, Wright J, Al-Turki S, McEntagart MM, Nair A, Chioza B, Al- Memar A, Modarres H, Reilly MM, Dick KJ, Ruggiero AM, Blakely RD, Hurles ME, Crosby AH (2012) Defective presynaptic choline transport underlies hereditary motor neuropathy. Am J Hum Genet 91:1103-1107. CrossRef Medline
5. Bazalakova MH, Wright J, Schneble EJ, McDonald MP, Heilman CJ, Levey AI, Blakely RD (2007) Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav 6:411-424. CrossRef Medline
6. Boix-Trelis N, Vale-Martínez A, Guillazo-Blanch G, Costa-Miserachs D, Martí-Nicolovius M (2006) Effects of nucleus basalis magnocellularis stimulation on a socially transmitted food preference and c-Fos expression. Learn Mem 13:783-793. CrossRef Medline
7. Demeter E, Sarter M, Lustig C (2008) Rats and humans paying attention: cross-species task development for translational research. Neuropsychology 22:787-799. CrossRef Medline
8. th Annual Meeting of the Cognitive Neuroscience Society, Montreal, QC, Canada, March.
9. Demeter E, Hernandez-Garcia L, Sarter M, Lustig C (2011) Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage 54:1518-1529. CrossRef Medline
10. Edeline JM, Hars B, Maho C, Hennevin E (1994) Transient and prolonged facilitation of tone-evoked responses induced by basal forebrain stimulations in the rat auditory cortex. Exp Brain Res 97:373-386. Medline
11. English BA, Hahn MK, Gizer IR, Mazei-Robison M, Steele A, Kurnik DM, Stein MA, Waldman ID, Blakely RD (2009) Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. J Neurodev Disord 1:252-263. CrossRef Medline
12. English BA, Appalsamy M, Diedrich A, Ruggiero AM, Lund D, Wright J, Keller NR, Louderback KM, Robertson D, Blakely RD (2010) Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. Am J Physiol Heart Circ Physiol 299:H799-H810. CrossRef Medline
13. Ferguson SM, Blakely RD (2004) The choline transporter resurfaces: new roles for synaptic vesicles? Mol Interv 4:22-37. CrossRef Medline
14. Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD (2003) Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 23:9697-9709. Medline
15. Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD (2004) Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci U S A 101:8762-8767. CrossRef Medline
16. Gates J Jr, Ferguson SM, Blakely RD, Apparsundaram S (2004) Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J Pharmacol Exp Ther 310:536-545. CrossRef Medline
17. Goard M, Dan Y (2009) Basal forebrain activation enhances cortical coding of natural scenes. Nat Neurosci 12:1444-1449. CrossRef Medline
18. Greenwald AG, Gonzalez R, Harris RJ, Guthrie D (1996) Effect sizes and p values: what should be reported and what should be replicated? Psychophysiology 33:175-183. CrossRef Medline
19. Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R (2008) Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav 7:487-495. CrossRef Medline
20. Hasselmo ME, Sarter M (2011) Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacol Rev 36:52-73. CrossRef
21. Holmstrand EC, Asafu-Adjei J, Sampson AR, Blakely RD, Sesack SR (2010) Ultrastructural localization of high-affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: differences in axon morphology and transporter distribution. J Comp Neurol 518:1908-1924. CrossRef Medline
22. Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M (2007) Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology 32:2074-2086. CrossRef Medline
23. Kus L, Borys E, Ping Chu Y, Ferguson SM, Blakely RD, Emborg ME, Kordower JH, Levey AI, Mufson EJ (2003) Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J Comp Neurol 463:341-357. CrossRef Medline
24. Manaker S, Wieczorek CM, Rainbow TC (1986) Identification of sodiumdependent, high-affinity choline uptake sites in rat brain with [3H]hemicholinium-3. J Neurochem 46:483-488. CrossRef Medline
25. Martinez V, Sarter M (2004) Lateralized attentional functions of cortical cholinergic inputs. Behav Neurosci 118:984-991. CrossRef Medline
26. McGaughy J, Kaiser T, Sarter M (1996) Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci 110:247-265. Medline
27. McLin DE 3rd, Miasnikov AA, Weinberger NM (2002) Induction of behavioral associative memory by stimulation of the nucleus basalis. Proc Natl Acad Sci U S A 99:4002-4007. CrossRef Medline
28. Mesulam M (2004) The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 11:43-49. CrossRef Medline
29. Misawa H, Nakata K, Matsuura J, Nagao M, Okuda T, Haga T (2001) Distribution of the high-affinity choline transporter in the central nervous system of the rat. Neuroscience 105:87-98. CrossRef Medline
30. Nuechterlein KH, Luck SJ, Lustig C, Sarter M (2009) CNTRICS final task selection: control of attention. Schizophr Bull 35:182-196. CrossRef Medline
31. Okuda T, Okamura M, Kaitsuka C, Haga T, Gurwitz D (2002) Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate. J Biol Chem 277:45315-45322. CrossRef Medline
32. Parikh V, Sarter M (2006) Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. J Neurochem 97:488-503. CrossRef Medline
33. Parikh V, Pomerleau F, Huettl P, Gerhardt GA, Sarter M, Bruno JP (2004) Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur J Neurosci 20: 1545-1554. CrossRef Medline
34. Parikh V, Apparsundaram S, Kozak R, Richards JB, Sarter M (2006) Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice. Neuroscience 141:379-389. CrossRef Medline
35. Parikh V, Kozak R, Martinez V, Sarter M (2007) Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 56:141-154. CrossRef Medline
36. Parikh V, Man K, Decker MW, Sarter M (2008) Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J Neurosci 28:3769-3780. CrossRef Medline
37. Parikh V, Ji J, Decker MW, Sarter M (2010) Prefrontal β2 subunitcontaining and α7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling. J Neurosci 30:3518-3530. CrossRef Medline
38. Pinthong M, Black SA, Ribeiro FM, Pholpramool C, Ferguson SS, Rylett RJ (2008) Activity and subcellular trafficking of the sodium-coupled choline transporter CHT is regulated acutely by peroxynitrite. Mol Pharmacol 73:801-812. CrossRef Medline
39. Ribeiro FM, Alves-Silva J, Volknandt W, Martins-Silva C, Mahmud H, Wilhelm A, Gomez MV, Rylett RJ, Ferguson SS, Prado VF, Prado MA (2003) The hemicholinium-3 sensitive high affinity choline transporter is internalized by clathrin-mediated endocytosis and is present in endosomes and synaptic vesicles. J Neurochem 87:136-146. CrossRef Medline
40. Ribeiro FM, Black SA, Cregan SP, Prado VF, Prado MA, Rylett RJ, Ferguson SS (2005) Constitutive high-affinity choline transporter endocytosis is determined by a carboxyl-terminal tail dileucine motif. J Neurochem 94:86-96. CrossRef Medline
41. Ribeiro FM, Black SA, Prado VF, Rylett RJ, Ferguson SS, Prado MA (2006) The "ins" and "outs" of the high-affinity choline transporter CHT1. J Neurochem 97:1-12. CrossRef Medline
42. Rizzoli SO, Betz WJ (2005) Synaptic vesicle pools. Nat Rev Neurosci 6:57-69. CrossRef Medline
43. Robinson TE, Green DJ (1980) Effects of hemicholinium-3 and choline on hippocampal electrical activity during immobility vs movement. Electroencephalogr Clin Neurophysiol 50:314-323. CrossRef Medline
44. Ruggiero AM, Wright J, Ferguson SM, Lewis M, Emerson KS, Iwamoto H, Ivy MT, Holmstrand EC, Ennis EA, Weaver CD, Blakely RD (2012) A nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake. ACS Chem Neurosci 3:767-781. CrossRef Medline
45. Saltarelli MD, Lowenstein PR, Coyle JT (1987) Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in rat striatal slices. Eur J Pharmacol 135:35-40. CrossRef Medline
46. Saltarelli MD, Yamada K, Coyle JT (1990) Phospholipase A2 and 3Hhemicholinium- 3 binding sites in rat brain: a potential second-messenger role for fatty acids in the regulation of high-affinity choline uptake. J Neurosci 10:62-72. Medline
47. Sarter M, Parikh V (2005) Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6:48-56. CrossRef Medline
48. Sarter M, Gehring WJ, Kozak R (2006) More attention must be paid: the neurobiology of attentional effort. Brain Res Rev 51:145-160. CrossRef Medline
49. Sarter M, Lustig C, Taylor SF (2012) Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Neuropharmacology 62:1544-1553. CrossRef Medline
50. Simon JR, Atweh S, Kuhar MJ (1976) Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J Neurochem 26:909-922. CrossRef Medline
51. St Peters M, Demeter E, Lustig C, Bruno JP, Sarter M (2011a) Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. J Neurosci 31:9760-9771. CrossRef Medline
52. St Peters M, Cherian AK, Bradshaw M, Sarter M (2011b) Sustained attention in mice: expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP). Behav Brain Res 225:574-583. CrossRef Medline
53. Van Beek AH, Claassen JA (2011) The cerebrovascular role of the cholinergic neural system in Alzheimer's disease. Behav Brain Res 221:537-542. CrossRef Medline
54. Wang B, Yang L, Wang Z, Zheng H (2007) Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter. Proc Natl Acad Sci U S A 104:14140-14145. CrossRef Medline
55. Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J (2001) Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 98:14096-14101. CrossRef Medline
56. Yamamura HI, Snyder SH (1972) Choline: high-affinity uptake by rat brain synaptosomes. Science 178:626-628. CrossRef Medline
57. Zurkovsky L, Bychkov E, Tsakem EL, Siedlecki C, Blakely RD, Gurevich EV (2013) Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity. Dis Model Mech 6:171-183. CrossRef Medline